Effect of Resveratrol on Oxidative and Inflammatory Stress in Liver and Spleen of Streptozotocin-Induced Type 1 Diabetic Rats

10.4077/CJP.2012.BAA012

Chih-Chun Chang；Chieh-Yu Chang；Jiung-Pang Huang；Li-Man Hung

type 1 diabetes mellitus ； liver ； spleen ； oxidative stress ； inflammation ； resveratrol

The Chinese Journal of Physiology

55卷3期（2012 / 06 / 01）

192 - 201

英文

It has been well known that both oxidative stress and inflammatory activity play crucial roles in the pathogenesis of type 1 diabetes mellitus (T1DM). Resveratrol (RSV), a naturally occurring polyphenol found in grapes and red wine, has recently been shown to exert potent anti-diabetic, anti-oxidative and anti-inflammatory actions. In the present study, we investigated the effect of RSV on oxidative stress and inflammatory response in the liver and spleen of streptozotocin (STZ)-induced type 1 diabetic animal models. Male Long-Evans rats were injected with 65 mg/kg STZ to induce diabetes for 2 weeks, and subsequently administrated with the dosage of 0.1 or 1 mg/kg/day RSV for 7 consecutive days. Hepatic and splenic tissues were dissected for evaluation of oxidative and inflammatory stress. Oxidative stress was assessed by quantification of oxidative indicators including superoxide anion content, lipid and protein oxidative products, as well as manganese superoxide dismutase (Mn-SOD) and nitro-tyrosine protein expression levels. Inflammatory stress was evaluated by the levels of nuclear factor κB (NF-κB) and the proinflammatory cytokine tumor necrosis factor α(TNF-α), interleukin 1β (IL-1β) and IL-6. The experimental results indicated that RSV significantly decreased oxidative stress (superoxide anion content, protein carbonyl level and Mn-SOD expression) in both tissues and hepatic inflammation (NF-κB and IL-1β), but implicated proinflammatory potential of RSV in diabetic spleen (TNF-α and IL-6). The results of this study suggest that RSV may serve as a potent antioxidant, but RSV possesses a proinflammatory potential in certain circumstances in diabetes.

1. Ates, O.,Cayli, S. R.,Yucel, N.,Altinoz, E.,Kocak, A.,Durak, M. A.,Turkoz, Y.,Yologlu, S.(2007).Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats.J. Clin. Neurosci.,14,256-260.
2. Ceriello, A.(2000).Oxidative stress and glycemic regulation.Metabolism,49,27-29.
3. Cheng, H. M.,Hsiang, C. Y.,Chen, G. W.,Wu, S. L.,Chen, J. C.,Huang, C. Y.,Bau, D. T.,Ho, T. Y.(2008).Inhibition of lipopolysaccharide- induced interleukin-1β and tumor necrosis factor-α production by menthone through nuclear factor-κB signaling pathway in HaCat cells.Chinese J. Physiol.,51,160-166.
4. Cignarella, A.,Minici, C.,Bolego, C.,Pinna, C.,Sanvito, P.,Gaion, R. M.,Puglisi, L.(2006).Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats.Nutr. Metab. Cardiovasc. Dis.,16,322-329.
5. de la Lastra, C. A.,Villegas, I.(2005).Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.Mol. Nutr. Food Res.,49,405-430.
6. de la Lastra, C. A.,Villegas, I.(2007).Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications.Biochem. Soc. Trans.,35,1156-1160.
7. Dirks Naylor, A. J.(2009).Cellular effects of resveratrol in skeletal muscle.Life Sci.,84,637-640.
8. Evans, J. L.,Goldfine, I. D.,Maddux, B. A.,Grodsky, G. M.(2002).Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes.Endocr. Rev.,23,599-622.
9. Gonzales, A. M.,Orlando, R. A.(2008).Curcumin and resveratrol inhibit nuclear factor-κB-mediated cytokine expression in adipocytes.Nutr. Metab. (Lond).,5,17.
10. Hernández Marco, R.,Codoñer Franch, P.,Pons Morales, S.,Del Castillo Villaescusa, C.,Boix García, L.,Valls Bellés, V.(2009).Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus.Pediatr. Nephrol.,24,121-127.
11. Huang, J. P.,Huang, S. S.,Deng, J. Y.,Chang, C. C.,Day, Y. J.,Hung, L.M.(2010).Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin.Free Radic. Biol. Med.,49,1710-1721.
12. Khan, M. M.,Ishrat, T.,Ahmad, A.,Hoda, M. N.,Khan, M. B.,Khuwaja, G.,Srivastava, P.,Raza, S. S.,Islam, F.,Ahmad, S.(2010).Sesamin attenuates behavioral, biochemical and histological alterations induced by reversible middle cerebral artery occlusion in the rats.Chem. Biol. Interact.,183,255-263.
13. Klinge, C. M.,Blankenship, K. A.,Risinger, K. E.,Bhatnagar, S.,Noisin, E. L.,Sumanasekera, W. K.,Zhao, L.,Brey, D. M.,Keynton, R. S.(2005).Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors α and β in endothelial cells.J. Biol. Chem.,280,7460-7468.
14. Manna, P.,Das, J.,Ghosh, J.,Sil, P.C.(2010).Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IκBα/NF-κB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid.Free Radic. Biol. Med.,48,1465-1484.
15. Manna, S. K.,Mukhopadhyay, A.,Aggarwal, B. B.(2000).Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation.J. Immunol.,164,6509-6519.
16. Mohamed, A. K.,Bierhaus, A.,Schiekofer, S.,Tritschler, H.,Ziegler, R.,Nawroth, P. P.(1999).The role of oxidative stress and NF-κB activation in late diabetic complications.Biofactors,10,157-167.
17. Palsamy, P.,Sivakumar, S.,Subramanian, S.(2010).Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats.Chem. Biol. Interact.,186,200-210.
18. Palsamy, P.,Subramanian, S.(2010).Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats.J. Cell. Physiol.,224,423-432.
19. Palsamy, P.,Subramanian, S.(2008).Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats.Biomed. Pharmacother.,62,598-605.
20. Sharma, S.,Anjaneyulu, M.,Kulkarni, S. K.,Chopra, K.(2006).Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats.Pharmacology,76,69-75.
21. Su, H. C.,Hung, L. M.Chen, J. K.(2006).Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocininduced diabetic rats.Am. J. Physiol. Endocrinol. Metab.,290,1339-1346.
22. Thirunavukkarasu, M.,Penumathsa, S. V.,Srikanth, K.,Juhasz, B.,Zhan, L.,Otani, H.,Bagchi, D.,Das, D. K.,Maulik, N.(2007).Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin and heme oxygenase.Free Radic. Biol. Med.,43,720-729.
23. Uchida, Y.,Yamazaki, H.,Watanabe, S.,Hayakawa, K.,Meng, Y.,Hiramatsu, N.,Kasai, A.,Yamauchi, K.,Yao, J.,Kitamura, M.(2005).Enhancement of NF-κB activity by resveratrol in cytokine-exposed mesangial cells.Clin. Exp. Immunol.,142,76-83.
24. Ungvari, Z.,Labinskyy, N.,Mukhopadhyay, P.,Pinto, J. T.,Bagi, Z.,Ballabh, P.,Zhang, C.,Pacher, P.,Csiszar, A.(2009).Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells.Am. J. Physiol. Heart Circ. Physiol.,297,H1876-H1881.
25. Zhang, H.,Zhang, J.,Ungvari, Z.,Zhang, C.(2009).Resveratrol improves endothelial function: role of TNFα and vascular oxidative stress.Arterioscler. Thromb. Vasc. Biol.,29,1164-1171.
26. Zimmerman, M. A.,Flores, S. C.(2009).Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.J. Surg. Res.,155,173-178.
27. Zivić, S.,Vlaski, J.,Kocić, G.,Pesić, M.,Cirić, V.,Durić, Z.(2008).The importance of oxidative stress in pathogenesis of type 1 diabetes-determination of catalase activity in lymphocytes of diabetic patients.Med. Pregl.,61,458-463.

1. Tarnoki, David L.,Tarnoki, Adam D.,Molnar, Andrea Agnes,Littvay, Levente,Karlinger, Kinga,Garami, Zsolt,Berczi, Viktor,Baffy, Gyorgy(2016).Environmental Factors Responsible for Variability of Hepatic Vein Flow: A Doppler Assessment in Healthy Twins.中國生理學雜誌,59(1),33-38.
2. Tarnoki, David L.,Tarnoki, Adam D.,Molnar, Andrea Agnes,Littvay, Levente,Karlinger, Kinga,Garami, Zsolt,Berczi, Viktor,Baffy, Gyorgy(2016).Environmental Factors Responsible for Variability of Hepatic Vein Flow: A Doppler Assessment in Healthy Twins.中國生理學雜誌,59(1),33-38.
3. Tzung-Hai Yen,Pei-Chun Lin,Li-Man Hung,Kuan-Hsing Chen,Jiung-Pang Huang,Chih-Chun Chang,Chieh-Yu Chang(2020).Administration of Low-dose Resveratrol Attenuated Hepatic Inflammation and Lipid Accumulation in High Cholesterol-fructose Diet-induced Rat Model of Nonalcoholic Fatty Liver Disease.The Chinese Journal of Physiology,63(4),149-155.
4. Wang, Yan-ling,Liu, Jian-pei,Liu, De-zhao,Huang, Pin-jie,Hei, Zi-qing,Gan, Xiao-liang(2014).Effects of Anti-Histamine Treatment on Liver Injury Triggered by Small Intestinal Ischemia Reperfusion in Rats.中國生理學雜誌,57(5),271-278.
5. Wu, Ming-Shun,Pan, Wen-Harn,Owaga, Eddy,Cheng, Shu-Yu,Chang, Jung-Su,Bai, Chyi-Huey(2014).Relationship between Hemoglobin Levels and Risk for Suspected Non-Alcoholic Fatty Liver in Taiwanese Adults.中國生理學雜誌,57(5),286-294.
6. Zhang, Yan-qing,Zhang, Ming-zhi,Sun, Qiu-ying,Song, Kai-Ian,Guan, Qing-bo,Feng, Mei,Cao, Ming-feng,Bian, Li-xiang(2014).Effects of Periodontal Treatment on Glycemic Control in Type 2 Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials.中國生理學雜誌,57(6),305-314.
7. Zhou, Qian,Zhai, Mingzhu,Sun, Wuping,Qian, Chengrui,Jiang, Changyu(2017).Effects of B Vitamins Overload on Plasma Insulin Level and Hydrogen Peroxide Generation in Rats.中國生理學雜誌,60(4),207-214.